Helicobacter pylori bacteria is considered to be the main cause of gastric cancer, with the infection rate particularly high ...

RedHill plans to submit UK MAA1 for Talicia for H. pylori infection, using MHRA's2 new fast-track approval process, referencing FDA approval, with potential UK approval ...

Curative Health Insurance Company is proud to have been named to Fast Company's prestigious list of the World's Most Innovative Companies of 2025. This year's list shines a spotlight on businesses ...

RedHill Biopharma Ltd. ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced its plan to submit a UK Marketing Authorisation Application (MAA) for Talicia for treatment ...

An international research group led by Osaka Metropolitan University researchers conducted a large-scale online survey of clinicians in the Asia-Pacific region to investigate treatment policies for ...

我国是胃癌高发地区，胃癌在我国常见恶性肿瘤中发病率位居第二，70%-80% 的早期胃癌无症状。早期胃癌的 5 年生存率高达 90% 以上，而晚期胃癌的 5 年生存率低于 10%，因此呼吁超过 40 岁且未曾做过胃肠镜检查的人一定要做一次胃肠镜检查。

About two-thirds of us have it in our bodies, but for most people, the bacterium Helicobacter pylori (H. pylori for short) ...

The search for extraterrestrial life continues, with Mars remaining a primary focus due to its geological features and past evidence of water. While no living organisms have been found, compounds and ...

The American College of Gastroenterology has published its first clinical guideline on the diagnosis and management of ...

A new editorial was published in Oncotarget, Volume 16, on March 10, 2025, titled “EXPOSOMES and GENES: The duo influencing ...

This week's round-up includes Notify Technology, Lant Medical, Fenwick and Colmans, Fairgrieve Compression Moulding and Steel ...

导 语奥美拉唑临床广泛使用。但长期或高剂量用药应警惕其可能产生的不良反应，具体都有哪些？一起来看看吧！奥美拉唑为质子泵抑制剂（PPIs）类抗消化性溃疡药物，临床主要用于治疗消化性溃疡、幽门螺杆菌感染、反流性食管炎、胃泌素瘤、卓-艾综合征等消化系统疾病。也可用于预防重症疾病（如脑出血、严重创伤等）手术后的再 ...